PepGen (PEPG) News
NASDAQ: PEPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.78-0.15 (-3.82%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PEPG news summary
We found 2 recent headlines mentioning PepGen (PEPG): 0 in the past week and 2 in the past 30 days, most often from Nasdaq, Business Wire. For price context, PEPG is down 3.82% at $3.78. The most recent story, "PepGen Prices $125 Mln Offering Of 25 Mln Shares At $5.00 Per Share; Stock Up", was published by Nasdaq on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest PepGen headlines
- PepGen Prices $125 Mln Offering Of 25 Mln Shares At $5.00 Per Share; Stock Up(RTTNews) - PepGen Inc. (PEPG), a clinical-stage biotechnology company, announced the pricing of a public offering of 25 million shares at $5.00 per share. The aggregate gross proceeds are expected…NasdaqPEPG, LEN.B
- PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate HighlightsBOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate HighlightsBusiness Wire